α_(1A)受体阻滞剂治疗慢性前列腺炎的疗效观察  

Study on efficacy of inhibitors of α_(1A)-receptor in chronic prostatitis

作　　者：郑立泉[1] 赵升田[2] 郭慧梅[1] 綦岩[1] 

机构地区：[1]泰山医学院附属医院泌尿外科,山东泰安271000 [2]山东大学第二医院,山东济南250033

出　　处：《泰山医学院学报》2008年第7期492-494,共3页Journal of Taishan Medical College

摘　　要：目的观察α1A受体阻滞剂治疗慢性前列腺炎的疗效。方法80例慢性前列腺炎患者被随机分为A、B两组,分别应用左氧氟沙星(A组)、α1A受体阻滞剂坦索络新和左氧氟沙星(B组)。观察其疗效并进行统计学分析。结果B组治疗前后前列腺症状评分(SFQ)、前列腺液常规、尿流率的改善率明显优于A组(P<0.01)。结论α1A受体阻滞剂对慢性前列腺炎有明显的治疗作用,可作为治疗慢性前列腺炎的有效药物。Objective： To evaluate therapeutic efficacy of inhibitors of α1A-receptor（tamsulosin） in chronic prostatitis. Methods ： Eighty cases were divided into A and B groups randomly, and treated differently as the following. Cases of group A were treated with levofloxacin only and group B with tamsulosin and levofloxacin. Symptom frequency questionnaire （SFQ）, prostaticus, uroflow were observed before therapy and 6 weeks after therapy. The cure rate was analysed statistically. Results： In 18 cases（56.25% ） of group A, the symptom disappeared or improved, in 17 cases （33.13%） , SFQ improved and in 15cases （46. 88% ）, WBC disappeared or lowered in EPS. In group B, the number was 32 （ 88.89% ）, 33 （91. 67% ） and 30（83.33% ）. Conclusion： Inhibitors of αlA-receptor has obvious therapeatic efficacy in CP, bacterial or nonbacterial, and can be an effective drug for them.

关 键 词：慢性前列腺炎 Α1A受体阻滞剂 疗效 

分 类 号：R697.3[医药卫生—泌尿科学]